FDA clears first US trial of brain implant for severe depression
Summary
Motif Neurotech wins FDA clearance for first human trial of a wireless brain implant targeting treatment-resistant depression in the U.S.
Description
Motif Neurotech wins FDA clearance for first human trial of a wireless brain implant targeting treatment-resistant depression in the U.S.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source